Ausgabe 4/2001
Inhalt (8 Artikel)
How long should angiotensin-converting enzyme inhibitors be given to patients following myocardial infarction: implications of the HOPE trial
Vernon VS Bonarjee, Kenneth Dickstein
Organizing the Carotid Revascularization Endarterectomy versus Stenting Trial (CREST): National Institutes of Health, Health Care Financing Administration, and industry funding
Robert W Hobson II, Virginia J Howard, Thomas G Brott, George Howard, Gary S Roubin, Robert DG Ferguson
Systematic adjudication of myocardial infarction end-points in an international clinical trial
Kenneth W Mahaffey, Robert A Harrington, Martijn Akkerhuis, Neal S Kleiman, Lisa G Berdan, Brian S Crenshaw, Barbara E Tardiff, Christopher B Granger, Ingrid DeJong, Manju Bhapkar, Petr Widimsky, Ramón Corbalon, Kerry L Lee, Jaap W Deckers, Maarten L Simoons, Eric J Topol, Robert M Califf
Disagreements between central clinical events committee and site investigator assessments of myocardial infarction endpoints in an international clinical trial: review of the PURSUIT study
Kenneth W Mahaffey, Robert A Harrington, Martijn Akkerhuis, Neal S Kleiman, Lisa G Berdan, Brian S Crenshaw, Barbara E Tardiff, Christopher B Granger, Ingrid DeJong, Manju Bhapkar, Petr Widimsky, Ramón Corbalon, Kerry L Lee, Jaap W Deckers, Maarten L Simoons, Eric J Topol, Robert M Califf
The role of dyslipidemia and statins in venous thromboembolism
Joel G Ray, Frits R Rosendaal
Platelet glycoprotein IIb/IIIa receptor blockade in coronary artery disease
Jassim Al Suwaidi, Amar M Salam